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Thirteen patients selected because of resistance to usual therapeutic procedures were
treated with pyridoxine ointment. Three failed to respond even though the concentration
of pyridoxine was increased to 50 mg. per gram.
Patients with the raw moist or secondarily infected fiexural type of seborrheic dermatitis
failed to respond to the ointment and sometimes were made worse by applying it. They
complained often of severe burning when the ointment was applied.
Acne vulgaris, acne rosacea and psoriasis were usually unaffected by the ointment.
SUIIMART AND CONCLUSIONS
1. Desoxypyridoxine, a pyridoxine antagonist, with or without a diet poor in vitamins
of the B complex will induce skin lesions which are similar to seborrheic dermatitis of the
sicca type.
2. These lesions clear in a few days when pyridoxine is added to the regime either by
oral or parenteral routes.
3. When pyridoxine is applied to a large area of the skin, all induced lesions, both local
and distant, disappear indicating that pyridoxine is easily absorbed by the skin.
4. When pyridoxine is applied topically to a small focal area of induced dermatitis, the
skin lesions disappear in this area. Distant lesions are unchanged. These experiments sug-
gest that pyridoxine can be converted in the skin to its metabolically active form, pyridoxal
phosphate.
5. Very large doses of pyridoxine given parenterally or orally had no therapeutic effect
on spontaneous seborrheic dermatitis of the sicca type but an ointment containing pyri-
doxine, 10 mg. per gram, induced healing of the lesions in 22 of 25 patients. These observa-
tions suggest that one type of seborrheic dermatitis is due to a metabolic defect in the skin
which increases the local requirement for pyridoxine.
6. There is no implication in this work that seborrheic dermatitis is due to a systemic
deficiency in pyridoxine. At the present time pyridoxine in an ointment should not be used
on the acute moist oozing forms of seborrheic dermatitis.
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ANNOUNCEMENT
The Pacific Dermatologic Association will hold its annual meeting at the
Palace Hotel in San Francisco August 29th to 31st, 1952. The guest speaker
will be Dr. Marcus R. Caro of Chicago. This year's program is under the chair-
manship of Dr. Nelson Paul Anderson of Los Angeles. Among the features will
be a demonstration of the Treponome Immobilization Test, reports on research
activities of the member universities, a clinical and histopathologic meeting and
a discussion of dermatologic economics.
